Records containing: Multiple Sclerosis (MS)
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-29A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension
-
CLINICAL_TRIALS study record update · 2026-04-13An Open-Label Clinical Study to Evaluate the Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
-
CLINICAL_TRIALS study record update · 2026-04-13A Clinical Study on the Safety and Tolerability of Universal STAR-T Cell Injection in Patients With Multiple Sclerosis.
-
CLINICAL_TRIALS study record update · 2026-03-30A 2-year Randomized, 3-arm, Double-blind, Non-inferiority Study Comparing the Efficacy and Safety of Ofatumumab and Siponimod Versus Fingolimod in Pediatric Patients With Multiple Sclerosis Followed by an Open-label Extension
-
CLINICAL_TRIALS study record update · 2026-03-19INFORM - Interferon-Beta Exposure in the 2nd and 3rd Trimester of Pregnancy - a Register-Based Drug Utilisation Study in Finland and Sweden
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-18Prevalence of Periodontal Disease Among Egyptian Patients With Multiple Sclerosis S: A Cross Sectional Study
-
CLINICAL_TRIALS study record update · 2026-03-16Brain Reorganization After Serious Game -Based Cognitive Rehabilitation in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-03-11A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair Therapy
-
CLINICAL_TRIALS study record update · 2026-03-05Spinal Cord Lesion Detection in Multiple Sclerosis Using Novel MRI Sequences: A Pilot Study
-
CLINICAL_TRIALS study record update · 2026-03-02Quantitative Susceptibility Mapping for Lesion Differentiation in Aging Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2026-02-06This is a Non-interventional, Prospective, Multicenter Study Conducted in France. The Primary Objective of This Study is to Describe the Quality of Life of MS Patients After Initiation of Treatment With Ofatumumab.
-
CLINICAL_TRIALS study record update · 2026-01-15An Exploratory Clinical Study of Anti-CD20/B-cell Maturation Antigen(BCMA) Chimeric Antigen Receptor Autologous T Cell Product (C-CAR168) in the Treatment of Central Nervous System Autoimmune Diseases Refractory to Standard Therapy
-
CLINICAL_TRIALS study record update · 2026-01-07The Effect of Aerobic Exercise on an Elliptical Trainer Versus a Treadmill, on Gait and Walking Abilities, Expressed in Dynamic Stability, Balance and Walking Speed, in People With Multiple Sclerosis (MS)
-
CLINICAL_TRIALS study record update · 2026-01-02Escalation vs. Induction Therapy Strategy in Patients With Early-Onset MS After Age 50
-
CLINICAL_TRIALS study record update · 2025-12-09Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis: Long Term Predictive Value (IMAGIN-DEAL in MS)
-
CLINICAL_TRIALS study record update · 2025-09-23A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-08-22Booster Effects With Autoimmune Treatments in Patients With Poor Response to Initial COVID-19 Vaccine (ACV01)
-
CLINICAL_TRIALS study record update · 2025-07-25An Exploratory Clinical Study of Cluster of Differentiation Antigen 20(CD20)/Anti-B-cell Maturation Antigen(BCMA) Chimeric Antigen Receptor Autologous T Cell Product (C-CAR168) in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
-
CLINICAL_TRIALS study record update · 2025-07-08A Phase Ib, Open-Label, Multicenter Study To Investigate The Pharmacokinetics, Safety, And Tolerability Of Subcutaneous Ocrelizumab Administration In Patients With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-06-11An Open Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of LCAR-AIO CAR-T Cells for Treating Relapsed/Refractory Neurological Autoimmune Diseases
-
CLINICAL_TRIALS study record update · 2025-05-31A Phase 1 Study of the Safety and Tolerability of Single and Multiple Doses of ANK-700 in Patients With Relapsing Remitting Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2025-05-02A Phase 1/2 Study to Evaluate Safety, PK and Biodistribution of an Imaging Agent, 18F-OP-801, After Intravenous Administration to Patients With ALS, Alzheimer's Disease, Multiple Sclerosis, Parkinson's Disease and Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2025-04-24A Phase 1, Open-label, Multi-part Study to Evaluate the Safety, Tolerability, Kinetics, Biodistribution, and CNS Signal of the Positron Emission Tomography Ligand 11C-BMS-986196 in Healthy Participants After Intravenous Administration and to Evaluate the Safety, Tolerability, Kinetics, and CNS Signal Repeatability of 11C-BMS-986196 After Repeat Intravenous Administration in Participants With Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-12-16INsIDER: Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis
-
CLINICAL_TRIALS study record update · 2024-11-29Virtual Memory Attention and Problem Solving Skills for Persons With MS (MAPSS-MS) Pilot